+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Peripheral Nerve Stimulators Market Forecast to 2033

  • PDF Icon

    Report

  • 300 Pages
  • October 2025
  • Region: United States
  • Grand View Research
  • ID: 6189402
REQUEST CUSTOMIZATION
Description Jump to:
The U.S. peripheral nerve stimulators market size was estimated at USD 105.14 million in 2024 and is projected to reach USD 253.36 million by 2033, growing at a CAGR of 10.43% from 2025 to 2033. The U.S. peripheral nerve stimulators industry is primarily driven by the rising prevalence of chronic pain conditions and increasing demand for minimally invasive, targeted pain management therapies, and the growing shift toward non-opioid therapies.

Growing awareness among healthcare providers and patients about the effectiveness of peripheral nerve stimulation in improving quality of life is fueling adoption. Technological advancements, including implantable systems, wearable stimulators, and enhanced programmable features, further propel market growth. The expansion of outpatient and ambulatory surgery centers, favorable reimbursement policies, and an aging population with higher surgical volumes contribute to the sustained momentum of the market.

Rising prevalence of chronic diseases continues to drive growth in the U.S. peripheral nerve stimulators industry, as patients with conditions such as diabetes, obesity, hypertension, asthma, and chronic pain increasingly require targeted, long-term pain management solutions. Peripheral nerve stimulators offer minimally invasive options to alleviate pain associated with these illnesses, improving patient outcomes and quality of life.

For instance, in April 2025, Health System Tracker highlighted that the U.S. has a higher rate of chronic diseases compared to peer nations, with over twice as many people affected by obesity and diabetes, 1.7 times more with asthma, and an overall higher burden of depression. This elevated prevalence of chronic conditions not only increases demand for advanced pain management therapies but also underscores the growing need for effective, clinically proven peripheral nerve stimulation solutions. According to the Pan American Health Organization’s (PAHO) report, in July 2025, cardiovascular diseases led with 2.16 million deaths, followed by cancer (1.37 million), diabetes (over 420,000), and chronic respiratory conditions (more than 416,000). Suicide, the fourth leading cause of death among youth aged 15-29, claimed 100,760 lives.

U.S. Peripheral Nerve Stimulators Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the U.S. peripheral nerve stimulators market report based on product type, modality, connectivity, application, and end use:

Product Type Outlook (Revenue, USD Million, 2021-2033)

  • Systems
  • Implantable
  • Non-implantable
  • Wearables/Accessories

Modality Outlook (Revenue, USD Million, 2021-2033)

  • Rechargeable
  • Non-rechargeable

Connectivity Outlook (Revenue, USD Million, 2021-2033)

  • Wired
  • Wireless

Application Outlook (Revenue, USD Million, 2021-2033)

  • Diabetic Peripheral Neuropathy Pain
  • Chronic Musculoskeletal Pain
  • Complex Regional Pain Syndrome (CRPS)
  • Headache and Migraine Disorders
  • Others

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Physiotherapy/Rehabilitation Centers
  • Others

Why You Should Buy This Report

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

Report Deliverables

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product Type
1.2.2. Modality
1.2.3. Connectivity
1.2.4. Application
1.2.5. End Use
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.5.5. Information Analysis
1.5.6. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. U.S. Peripheral Nerve Stimulators Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. High and rising prevalence of chronic pain
3.2.1.2. Shift away from opioids toward non-opioid/interventional therapies
3.2.1.3. Evidence and real-world adoption showing clinical benefit
3.2.2. Market Restraint Analysis
3.2.2.1. High device and procedure costs
3.2.2.2. Technological limitations
3.2.3. Market Opportunities Analysis
3.2.3.1. Outpatient centers and ambulatory surgery as key settings
3.2.3.2. Aging population and comorbidities
3.2.4. Market Challenges Analysis
3.2.4.1. Device-related risks and complications
3.2.4.2. Intense market competition
3.3. U.S. Peripheral Nerve Stimulators Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. U.S. Peripheral Nerve Stimulators Market: Product Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. U.S. Peripheral Nerve Stimulators Market Product Type Movement Analysis
4.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
4.4. Systems
4.4.1. Systems U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.1.1. Implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.1.1.1. Handheld
4.4.1.1.2. Others
4.4.1.2. Non-implantable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Wearables/Accessories
4.5.1. Wearables/Accessories U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. U.S. Peripheral Nerve Stimulators Market: Modality Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. U.S. Peripheral Nerve Stimulators Market Modality Movement Analysis
5.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
5.4. Rechargeable
5.4.1. Rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Non-rechargeable
5.5.1. Non-rechargeable U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. U.S. Peripheral Nerve Stimulators Market: Connectivity Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
6.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
6.4. Wired
6.4.1. Wired U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
6.5. Wireless
6.5.1. Wireless U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 7. U.S. Peripheral Nerve Stimulators Market: Application Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. U.S. Peripheral Nerve Stimulators Market Connectivity Movement Analysis
7.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
7.4. Diabetic Peripheral Neuropathy Pain
7.4.1. Diabetic Peripheral Neuropathy Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Chronic Musculoskeletal Pain
7.5.1. Chronic Musculoskeletal Pain U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Complex Regional Pain Syndrome (CRPS)
7.6.1. Complex Regional Pain Syndrome (CRPS) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Headache and Migraine Disorders
7.7.1. Headache and Migraine Disorders U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Others
7.8.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. U.S. Peripheral Nerve Stimulators Market: End-Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. U.S. Peripheral Nerve Stimulators Market End-Use Movement Analysis
8.3. U.S. Peripheral Nerve Stimulators Market Size & Trend Analysis, by End-Use, 2021 to 2033 (USD Million)
8.4. Hospitals and Clinics
8.4.1. Hospitals and Clinics U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.5. Ambulatory Surgical Centers (ASCs)
8.5.1. Ambulatory Surgical Centers (ASCs) U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.6. Physiotherapy/Rehabilitation Centers
8.6.1. Physiotherapy/Rehabilitation Centers U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
8.7. Others
8.7.1. Others U.S. Peripheral Nerve Stimulators Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Key Company Profiles
9.2.1. B. Braun Medical Inc.
9.2.1.1. Company Overview
9.2.1.2. Financial Performance
9.2.1.3. Modality Benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. Nalu Medical, Inc
9.2.2.1. Company Overview
9.2.2.2. Financial Performance
9.2.2.3. Modality Benchmarking
9.2.2.4. Strategic Initiatives
9.2.3. Curonix LLC.
9.2.3.1. Company Overview
9.2.3.2. Financial Performance
9.2.3.3. Modality Benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. SPR
9.2.4.1. Company Overview
9.2.4.2. Financial Performance
9.2.4.3. Modality Benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. Vygon
9.2.5.1. Company Overview
9.2.5.2. Financial Performance
9.2.5.3. Modality Benchmarking
9.2.5.4. Strategic Initiatives
9.2.6. AirLife
9.2.6.1. Company Overview
9.2.6.2. Financial Performance
9.2.6.3. Modality Benchmarking
9.2.6.4. Strategic Initiatives
9.2.7. Neuspera Medical
9.2.7.1. Company Overview
9.2.7.2. Financial Performance
9.2.7.3. Modality Benchmarking
9.2.7.4. Strategic Initiatives
9.2.8. Anesthesia Associates, Inc.
9.2.8.1. Company Overview
9.2.8.2. Financial Performance
9.2.8.3. Modality Benchmarking
9.2.8.4. Strategic Initiatives
9.2.9. AVNS
9.2.9.1. Company Overview
9.2.9.2. Financial Performance
9.2.9.3. Modality Benchmarking
9.2.9.4. Strategic Initiatives
9.2.10. Mercury Medical
9.2.10.1. Company Overview
9.2.10.2. Financial Performance
9.2.10.3. Modality Benchmarking
9.2.10.4. Strategic Initiatives
9.2.11. Medtronic
9.2.11.1. Company Overview
9.2.11.2. Financial Performance
9.2.11.3. Modality Benchmarking
9.2.11.4. Strategic Initiatives
9.2.12. Boston Scientific Corporation
9.2.12.1. Company Overview
9.2.12.2. Financial Performance
9.2.12.3. Modality Benchmarking
9.2.12.4. Strategic Initiatives
9.2.13. Abbott
9.2.13.1. Company Overview
9.2.13.2. Financial Performance
9.2.13.3. Modality Benchmarking
9.2.13.4. Strategic Initiatives
9.2.14. Bioventus
9.2.14.1. Company Overview
9.2.14.2. Financial Performance
9.2.14.3. Modality Benchmarking
9.2.14.4. Strategic Initiatives
9.2.15. Checkpoint Surgical Inc.
9.2.15.1. Company Overview
9.2.15.2. Financial Performance
9.2.15.3. Modality Benchmarking
9.2.15.4. Strategic Initiatives
9.2.16. Nervonik, Inc
9.2.16.1. Company Overview
9.2.16.2. Financial Performance
9.2.16.3. Modality Benchmarking
9.2.16.4. Strategic Initiatives
9.3. Company Market Share Analysis, 2024
9.4. List of Other Key Market Players
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 U.S. Peripheral Nerve Stimulators Market, by Product Type, 2021-2033 (USD Million)
Table 4 U.S. Peripheral Nerve Stimulators Market, by Modality, 2021-2033 (USD Million)
Table 5 U.S. Peripheral Nerve Stimulators Market, by Connectivity, 2021-2033 (USD Million)
Table 6 U.S. Peripheral Nerve Stimulators Market, by Application, 2021-2033 (USD Million)
Table 7 U.S. Peripheral Nerve Stimulators Market, by End-Use, 2021-2033 (USD Million)
Table 8 Participant’s Overview
Table 9 Financial Performance
Table 10 Modality Benchmarking
Table 11 Strategic Initiatives
List of Figures
Figure 1 Information Procurement
Figure 2 Primary Research Pattern
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 U.S. Peripheral Nerve Stimulators Market, Market Segmentation
Figure 7 Market Driver Analysis (Current & Future Impact)
Figure 8 Market Restraint Analysis (Current & Future Impact)
Figure 9 Market Opportunity Analysis (Current & Future Impact)
Figure 10 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
Figure 11 Porter’s Five Forces Analysis
Figure 12 Regional Marketplace: Key Takeaways
Figure 13 U.S. Peripheral Nerve Stimulators Market, for Product Type, 2021-2033 (USD Million)
Figure 14 U.S. Peripheral Nerve Stimulators Market, for Systems, 2021-2033 (USD Million)
Figure 15 U.S. Peripheral Nerve Stimulators Market, for Implantable, 2021-2033 (USD Million)
Figure 16 U.S. Peripheral Nerve Stimulators Market, for Non-Implantable, 2021-2033 (USD Million)
Figure 17 U.S. Peripheral Nerve Stimulators Market, for Handheld, 2021-2033 (USD Million)
Figure 18 U.S. Peripheral Nerve Stimulators Market, for Others, 2021-2033 (USD Million)
Figure 19 U.S. Peripheral Nerve Stimulators Market, for Wearables/Accessories, 2021-2033 (USD Million)
Figure 20 U.S. Peripheral Nerve Stimulators Market, for Rechargeable, 2021-2033 (USD Million)
Figure 21 U.S. Peripheral Nerve Stimulators Market, for Non-rechargeable, 2021-2033 (USD Million)
Figure 22 U.S. Peripheral Nerve Stimulators Market, for Connectivity, 2021-2033 (USD Million)
Figure 23 U.S. Peripheral Nerve Stimulators Market, for Wired, 2021-2033 (USD Million)
Figure 24 U.S. Peripheral Nerve Stimulators Market, for Wireless, 2021-2033 (USD Million)
Figure 25 U.S. Peripheral Nerve Stimulators Market, for Application, 2021-2033 (USD Million)
Figure 26 U.S. Peripheral Nerve Stimulators Market, for Diabetic Peripheral Neuropathy Pain, 2021-2033 (USD Million)
Figure 27 U.S. Peripheral Nerve Stimulators Market, for Chronic Musculoskeletal Pain, 2021-2033 (USD Million)
Figure 28 U.S. Peripheral Nerve Stimulators Market, for Complex Regional Pain Syndrome (CRPS), 2021-2033 (USD Million)
Figure 29 U.S. Peripheral Nerve Stimulators Market, for Headache and Migraine Disorders, 2021-2033 (USD Million)
Figure 30 U.S. Peripheral Nerve Stimulators Market, for Others, 2021-2033 (USD Million)
Figure 31 U.S. Peripheral Nerve Stimulators Market, for End Use, 2021-2033 (USD Million)
Figure 32 U.S. Peripheral Nerve Stimulators Market, for Hospitals and Clinics, 2021-2033 (USD Million)
Figure 33 U.S. Peripheral Nerve Stimulators Market, for Ambulatory Surgical Centers (ASCs), 2021-2033 (USD Million)
Figure 34 U.S. Peripheral Nerve Stimulators Market, for Physiotherapy/Rehabilitation Centers, 2021-2033 (USD Million)
Figure 35 U.S. Peripheral Nerve Stimulators Market, for Others, 2021-2033 (USD Million)

Companies Mentioned

The companies profiled in this U.S. Peripheral Nerve Stimulators market report include:
  • B. Braun Medical Inc.
  • Nalu Medical, Inc
  • Curonix LLC.
  • SPR
  • Vygon
  • AirLife
  • Neuspera Medical
  • Anesthesia Associates, Inc.
  • AVNS
  • Mercury Medical
  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Bioventus
  • Checkpoint Surgical Inc.
  • Nervonik, Inc

Table Information

Report AttributeDetails
No. of Pages300
PublishedOctober 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 105.14 Million
Forecasted Market Value ( USD ) by 2033 $ 253.36 Million
Compound Annual Growth Rate10.4%
Regions CoveredUnited States
No. of Companies Mentioned17

Related Topics

Related Reports

Peripheral Nerve Stimulators Market Size, Share & Trends Analysis Report by Product (Systems, Wearables/Accessories), Modality (Rechargeable, Non-Rechargeable), Application (Diabetic Peripheral Neuropathy Pain), Connectivity, End Use, and Region with Growth Forecasts, 2025-2033 - Product Image

Peripheral Nerve Stimulators Market Size, Share & Trends Analysis Report by Product (Systems, Wearables/Accessories), Modality (Rechargeable, Non-Rechargeable), Application (Diabetic Peripheral Neuropathy Pain), Connectivity, End Use, and Region with Growth Forecasts, 2025-2033

  • Report
  • 300 Pages
  • Global
From
United States Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others - Product Image

United States Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

  • Report
  • 94 Pages
  • United States
From
United Kingdom Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others - Product Image

United Kingdom Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

  • Report
  • 66 Pages
  • United Kingdom
From
France Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others - Product Image

France Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

  • Report
  • 57 Pages
  • France
From
Spain Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others - Product Image

Spain Neuromodulation Devices Market Outlook to 2033 - Deep Brain Stimulators (DBS), Spinal Cord Stimulators (SCS), Vagus Nerve Stimulators (VNS) and Others

  • Report
  • 56 Pages
  • Spain
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.